Finland – Medical equipments, pharmaceuticals and personal care products – HbA1c-vieritestausanalytiikka HUS Diagnostiikkakeskuksen hoitoyksikköasiakkaille ja laboratorioihin

The HUS Group invites tenders for HbA1c point-of-care testing analytics for the use of HUS Diagnostic Centre's care unit customers and laboratories. The subject of the procurement are HbA1c point-of-care testing devices with accessories. HbA1c point-of-care testing is carried out for the care unit customers of HUS Diagnostic Centre (hereinafter HUS DGK). HUS DGK offers HbA1c point-of-care testing support services to well-being services counties and specialised healthcare, procures the devices and delivers them to its care unit customers in HUS and the well-being services counties of Uusimaa, Kymenlaakso and South Karelia. The customers of the Point-of-Care Testing Unit of HUS Diagnostic Centre, HUS, Helsinki, the well-being services counties of Uusimaa, South Karelia and Kymenlaakso are entitled to order the products that are the subject of this agreement. The support service customers order the reagents and controls they need from HUS or the well-being services county's ordering system at the prices specified in the tender of the winning tenderer in this tendering process. HUS DGK defines for the tenderers which customers are customers of the point-of-care testing support service of HUS DGK. HUS DGK orders the devices and delivers them to its customers. The user base of the care units is wide and the usage environments are varied. Due to the varied operating environments of the users, multiple contract suppliers are chosen for the sub-areas of the HbA1c desktop model point-of-care testing devices. Orders are made in accordance with the priority order (more detailed information later in the tender invitation). One contract supplier is chosen for the other sub-areas. The devices and the reagents and controls used are verified at HUS DGK. In addition, HUS DGK makes device connections to patient data systems if necessary in cooperation with the device supplier. In addition, the support service customers are guided and supported in the use of the devices. Currently, there are approximately 77 HbA1c devices in use. The estimated production quantities per test have been reported later in the tender invitation. The procurement is divided into parts as follows: 1. HbA1C desktop device (incl. accessories) 2. Accessories for the existing Afinion 2 device fleet for HbA1c tests. Sub-tenders are allowed: the tenderer may submit a tender for one or more parts of the procurement. The contract period of the procurement is 4 years, after which it continues indefinitely. The current device fleet in use, purchased by HUS itself, is replaced so that the devices are planned to be renewed during the contract period as device failures occur and the life cycle of the old devices ends. When the new contract enters into force, new devices are purchased from the new device contract, but consumables for old devices are purchased separately according to the tender invitation until the need for device replacement becomes apparent. In addition, an old device can be replaced with a new one, based on this tender, due to the nature of the user unit's operation (e.g. local care practices, the device's wider features). The test quantities are divided between the existing devices and the new devices. The estimated quantity for orders (devices + accessories) has been reported for each sub-area for the entire contract period. The purchaser is not committed to any minimum order quantity, and the contract does not create a purchase obligation for the purchaser. The devices and test quantities as well as the consumption quantities of the options reported in the tender invitation are indicative and directional and do not bind the Purchaser and have been given to the Supplier to support the preparation of the tender. The final consumption quantities may be larger or smaller than the reported examples and are divided among multiple contract partners. The aim of the tender is to obtain a selection of safe and reliable products, taking into account the wide user base. The aim is also that the delivery reliability of the products is good and that the products are available when they are needed. During the contract period, it is also possible to procure products belonging to the product groups that are the subject of the procurement, in accordance with the anticipated value of the procurement, which have not been identified in the product specification (see procurement contract). The estimated total value of the procurement (VAT 0 %) is approximately 400,000 euros/48 months. This is an estimate, and the procurement unit is not committed to the reported euro amounts and the consumption quantities reported in the tender invitation. The final order quantities may be larger or smaller than reported. The subject of the procurement and the requirements related to it are described in detail in the tender invitation and its appendices.